194 related articles for article (PubMed ID: 20177800)
1. Inhibitory effects of devil's claw (secondary root of Harpagophytum procumbens) extract and harpagoside on cytokine production in mouse macrophages.
Inaba K; Murata K; Naruto S; Matsuda H
J Nat Med; 2010 Apr; 64(2):219-22. PubMed ID: 20177800
[TBL] [Abstract][Full Text] [Related]
2. Alteration of anti-inflammatory activity of Harpagophytum procumbens (devil's claw) extract after external metabolic activation with S9 mix.
Hostanska K; Melzer J; Rostock M; Suter A; Saller R
J Pharm Pharmacol; 2014 Nov; 66(11):1606-14. PubMed ID: 25175765
[TBL] [Abstract][Full Text] [Related]
3. Effects of Devil's Claw (Harpagophytum procumbens) on the multidrug transporter ABCB1/P-glycoprotein.
Romiti N; Tramonti G; Corti A; Chieli E
Phytomedicine; 2009 Dec; 16(12):1095-100. PubMed ID: 19577448
[TBL] [Abstract][Full Text] [Related]
4. Harpagoside Content in Devil's Claw Extracts.
Kondamudi N; Turner MW; McDougal OM
Nat Prod Commun; 2016 Sep; 11(9):1215-1216. PubMed ID: 30807002
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of iNOS expression in rat mesangial cells by special extracts of Harpagophytum procumbens derives from harpagoside-dependent and independent effects.
Kaszkin M; Beck KF; Koch E; Erdelmeier C; Kusch S; Pfeilschifter J; Loew D
Phytomedicine; 2004 Nov; 11(7-8):585-95. PubMed ID: 15636171
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of harpagoside in horses after intragastric administration of a Devil's claw (Harpagophytum procumbens) extract.
Axmann S; Hummel K; Nöbauer K; Razzazi-Fazeli E; Zitterl-Eglseer K
J Vet Pharmacol Ther; 2019 Jan; 42(1):37-44. PubMed ID: 30242850
[TBL] [Abstract][Full Text] [Related]
7. Effect of isolated fractions of Harpagophytum procumbens D.C. (devil's claw) on COX-1, COX-2 activity and nitric oxide production on whole-blood assay.
Anauate MC; Torres LM; de Mello SB
Phytother Res; 2010 Sep; 24(9):1365-9. PubMed ID: 20812280
[TBL] [Abstract][Full Text] [Related]
8. Effect of the major glycosides of Harpagophytum procumbens (Devil's Claw) on epidermal cyclooxygenase-2 (COX-2) in vitro.
Abdelouahab N; Heard C
J Nat Prod; 2008 May; 71(5):746-9. PubMed ID: 18412394
[TBL] [Abstract][Full Text] [Related]
9. Optimization of Aqueous Extraction and Biological Activity of Harpagophytum procumbens Root on Ex Vivo Rat Colon Inflammatory Model.
Locatelli M; Ferrante C; Carradori S; Secci D; Leporini L; Chiavaroli A; Leone S; Recinella L; Orlando G; Martinotti S; Brunetti L; Vacca M; Menghini L
Phytother Res; 2017 Jun; 31(6):937-944. PubMed ID: 28447368
[TBL] [Abstract][Full Text] [Related]
10. Iridoid glycosides from Harpagophytum procumbens D.C. (devil's claw).
Qi J; Chen JJ; Cheng ZH; Zhou JH; Yu BY; Qiu SX
Phytochemistry; 2006 Jul; 67(13):1372-7. PubMed ID: 16857222
[TBL] [Abstract][Full Text] [Related]
11. Harpagoside: from Kalahari Desert to pharmacy shelf.
Georgiev MI; Ivanovska N; Alipieva K; Dimitrova P; Verpoorte R
Phytochemistry; 2013 Aug; 92():8-15. PubMed ID: 23642455
[TBL] [Abstract][Full Text] [Related]
12. The Fight against Infection and Pain: Devil's Claw (
Gxaba N; Manganyi MC
Molecules; 2022 Jun; 27(11):. PubMed ID: 35684573
[No Abstract] [Full Text] [Related]
13. Harpagoside suppresses IL-6 expression in primary human osteoarthritis chondrocytes.
Haseeb A; Ansari MY; Haqqi TM
J Orthop Res; 2017 Feb; 35(2):311-320. PubMed ID: 27082319
[TBL] [Abstract][Full Text] [Related]
14. Rapid measurement and evaluation of the effect of drying conditions on harpagoside content in Harpagophytum procumbens (devil's claw) root.
Joubert E; Manley M; Gray BR; Schulz H
J Agric Food Chem; 2005 May; 53(9):3493-502. PubMed ID: 15853393
[TBL] [Abstract][Full Text] [Related]
15. Toxicology studies of aqueous-alcohol extracts of Harpagophytum procumbens subsp. procumbens (Burch.) DC.Ex Meisn. (Pedaliaceae) in female and male rats.
Joshi K; Parrish A; Grunz-Borgmann EA; Gerkovich M; Folk WR
BMC Complement Med Ther; 2020 Jan; 20(1):9. PubMed ID: 32020872
[TBL] [Abstract][Full Text] [Related]
16. Devil's Claw (Harpagophytum procumbens): no evidence for anti-inflammatory activity in the treatment of arthritic disease.
Whitehouse LW; Znamirowska M; Paul CJ
Can Med Assoc J; 1983 Aug; 129(3):249-51. PubMed ID: 6407745
[TBL] [Abstract][Full Text] [Related]
17. Molecular targets of the antiinflammatory Harpagophytum procumbens (devil's claw): inhibition of TNFα and COX-2 gene expression by preventing activation of AP-1.
Fiebich BL; Muñoz E; Rose T; Weiss G; McGregor GP
Phytother Res; 2012 Jun; 26(6):806-11. PubMed ID: 22072539
[TBL] [Abstract][Full Text] [Related]
18. Protective Effects Induced by Microwave-Assisted Aqueous Harpagophytum Extract on Rat Cortex Synaptosomes Challenged with Amyloid β-Peptide.
Ferrante C; Recinella L; Locatelli M; Guglielmi P; Secci D; Leporini L; Chiavaroli A; Leone S; Martinotti S; Brunetti L; Vacca M; Menghini L; Orlando G
Phytother Res; 2017 Aug; 31(8):1257-1264. PubMed ID: 28635142
[TBL] [Abstract][Full Text] [Related]
19. Isolation and anti-inflammatory activity evaluation of triterpenoids and a monoterpenoid glycoside from Harpagophytum procumbens.
Qi J; Li N; Zhou JH; Yu BY; Qiu SX
Planta Med; 2010 Nov; 76(16):1892-6. PubMed ID: 20577946
[TBL] [Abstract][Full Text] [Related]
20. Harpagoside suppresses lipopolysaccharide-induced iNOS and COX-2 expression through inhibition of NF-kappa B activation.
Huang TH; Tran VH; Duke RK; Tan S; Chrubasik S; Roufogalis BD; Duke CC
J Ethnopharmacol; 2006 Mar; 104(1-2):149-55. PubMed ID: 16203115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
